These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment]. Bayard F, Louvet JP, Moatti JP, Smilovici W, Duguet L, Boulard C. J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402 [Abstract] [Full Text] [Related]
3. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. Carr BR, Parker CR, Madden JD, MacDonald PC, Porter JC. J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073 [Abstract] [Full Text] [Related]
4. Accumulation of ethinylestradiol in blood and endometrium of women taking oral contraceptives: the sequential therapy. Cortés-Gallegos V, Carranco A, Sojo I, Navarrette M, Cervantes C, Parra A. Fertil Steril; 1979 Nov; 32(5):524-7. PubMed ID: 499582 [Abstract] [Full Text] [Related]
5. The effect of ampicillin on oral contraceptive effectiveness. Friedman CI, Huneke AL, Kim MH, Powell J. Obstet Gynecol; 1980 Jan; 55(1):33-7. PubMed ID: 7188714 [Abstract] [Full Text] [Related]
6. Influence of oral contraceptives on immediate postabortal pituitary-ovarian function. Lähteenmäki P. Acta Obstet Gynecol Scand Suppl; 1978 Jan; 76():1-43. PubMed ID: 696249 [No Abstract] [Full Text] [Related]
7. [Hormonal tissue concentration and oral contraceptives: the endometrium]. Carranco López A, Sojo Aranda I, Alonso Uriarte R, Castañeda Peña G, Bedolla Tovar N, Navarrete Arellano M, Cortés Gallegos V. Ginecol Obstet Mex; 1979 Apr; 45(270):329-47. PubMed ID: 456926 [Abstract] [Full Text] [Related]
8. Effects of a synthetic estrogen-progestogen agent on urinary gonadotropin levels of FSA and LH using a radioimmunologic method. Forleo R, Vegna G, Pala A. Acta Eur Fertil; 1972 Jun; 3(2):159-76. PubMed ID: 4679575 [No Abstract] [Full Text] [Related]
9. [The efficacy of gestoden (delta 15-d-norgestrel) as ovulation inhibitor (author's transl)]. Schneider WH, Schmid R, Spona J. Wien Klin Wochenschr; 1981 Oct 16; 93(19):601-4. PubMed ID: 6798765 [Abstract] [Full Text] [Related]
10. [The effect of different types of oral contraceptives upon ovarian function (author's transl)]. Aktories K, Krög W, Dericks-Tan JS, Jürgensen O, Taubert HD. Geburtshilfe Frauenheilkd; 1976 Apr 16; 36(4):318-26. PubMed ID: 1269893 [Abstract] [Full Text] [Related]
11. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen. Jespersen J, Kluft C. Scand J Clin Lab Invest; 1982 Nov 16; 42(7):563-6. PubMed ID: 6818678 [Abstract] [Full Text] [Related]
12. [The effect of oral ovulation inhibiting (mono-, bi- and triphase) contraceptives and of Continuin and Postinor on proteo- and steroid hormones]. Farkas M. Acta Pharm Hung; 1992 Nov 16; 62(1-2):17-30. PubMed ID: 1566635 [Abstract] [Full Text] [Related]
13. Studies on low-dose oral contraceptives: cervical mucus and plasma hormone changes in relation to circulating D-norgestrel and 17alpha ethynyl-estradiol concentrations. Elstein M, Morris SE, Groom GV, Jenner DA, Scarisbrick JJ, Cameron EH. Fertil Steril; 1976 Aug 16; 27(8):892-9. PubMed ID: 955131 [Abstract] [Full Text] [Related]
14. The effect of oral contraceptives on the gonadotropin response to LHRH. Rubinstein L, Moguilevsky J, Leiderman S. Obstet Gynecol; 1978 Nov 16; 52(5):571-4. PubMed ID: 364356 [Abstract] [Full Text] [Related]
15. [Clinical pharmacology of hormonal contraceptives]. Hubinont PO, Degueldre M, Delvoye P, L'Hermite M, Robyn C, Vekemans M. Bull Mem Acad R Med Belg; 1975 Nov 16; 130(7-9):351-67. PubMed ID: 800347 [No Abstract] [Full Text] [Related]
19. Complications of oral contraceptive agents--a symposium. Action and efficacy of systemic contraceptive agents, and introduction of complications. Swerdloff RS. West J Med; 1975 Jan 16; 122(1):20-6. PubMed ID: 1089002 [No Abstract] [Full Text] [Related]